Recent Updates
Recently added Catalysts
ANTX Positive Sentiment

AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference

Key Takeaway: AN2 Therapeutics, Inc. announced its participation in the 9th Annual Evercore Healthcare Conference. CEO Eric Easom will engage in a fireside chat on December 2, 2026, at 8:20 am ET. Management will also be available for one-on-one meetings. A webcast of the chat will be accessible on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a notable healthcare conference
  • Opportunity for 1x1 meetings with management
  • Webcast availability enhances investor access

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+55%
120-day peak, hindsight
Typical move
2.5%
average across 4 past catalysts
Cash runway
~39 mo
Low dilution risk
Lead asset
Epetraborole
Phase 2 · Polycythemia Vera (SNOMED CT: 109992005)

Full Press Release Details

AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on Wednesday, December 2, 2026 at 8:20am ET and members of management will be available for 1x1 meetings.
A webcast of the fireside chat can be accessed on the Investors section of the AN2 Therapeutics website at www.an2therapeutics.com. An archived replay will be available for at least 30 days following the presentation.
About AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from its boron chemistry platform. For more information please visit our website at www.an2therapeutics.com.

Frequently Asked Questions

When will AN2 Therapeutics participate in the conference?

AN2 Therapeutics will participate on December 2, 2026.

Who will represent AN2 Therapeutics at the conference?

CEO Eric Easom will participate in a fireside chat.

How can investors access the webcast?

The webcast can be accessed on the AN2 Therapeutics website.

Will there be opportunities for one-on-one meetings?

Yes, management will be available for 1x1 meetings.

Last updated: Nov 20, 2026